Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 2
1(33.3%)
3Total
Phase 4(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06454292Phase 4Not Yet Recruiting

Efficacy and Safety Studies of Oliceridine Fumarate

Role: lead

NCT04372342Phase 4Unknown

The Effect of Analgesic Drugs on Respiratory Center

Role: lead

NCT03085459Completed

Effects of Nursing Staff on Empiric Antibiotic in Septic Shock

Role: lead

NCT02883231Unknown

Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance

Role: lead

NCT02795091Phase 2Unknown

Comparision of Different Methods of Enviromennt Disinfection

Role: lead

All 5 trials loaded